This IVD market in the US research report extensively covers market segmentation in the US by technology (immunochemistry, molecular diagnostics, tissue diagnostics, hematology, and others) and component (consumables, instruments, and services). Request Free Sample Report.
The growing competition in the market is compelling vendors to adopt various growth strategies such as promotional activities and spending on advertisements to improve the visibility of their services. Some vendors are also adopting inorganic growth strategies such as M&As to remain competitive in the market.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
Major Five IVD in US Companies:
- Abbott Laboratories: The company offers products for rhythm management, electrophysiology, heart failure, vascular, structural heart, and neuromodulation.
- Becton Dickinson and Co.: The company offers a wide range of IVD devices such as blood culture systems, clinical microbiology, dehydrated culture media, and Point care testing among others.
- Bio Rad Laboratories Inc.: The company offers a wide range of IVD devices, namely CFX96 in vitro diagnostics and real-time PCR systems.
- bioMerieux SA: The company offers a range of products under the head immunoassay, microbiology, molecular diagnosis, performance management, and lab automation.
- Danaher Corp.: The company offers a wide range of IVD devices through its brands Beckman Coulter, Leica Biosystems, and Radiometer.
Technavio's sample reports contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Download Free Sample Report.
Technavio categorizes the IVD market in the US as a part of the global healthcare equipment market within the global Health Care industry. The end-to-end understanding of the value chains is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
The value chain of the healthcare equipment market includes the following core components:
- Research and development
- Inputs
- Operations
- Distribution
- Marketing and sales
- Post-sales and services
- Industry innovations
For additional information related to market growth factors Buy Sample Report.
Related Reports:
Patch-based Wound Healing Market by Application and Geography - Forecast and Analysis 2022-2026: The patch-based wound healing market share is expected to increase by USD 329.13 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 4.8%.
Transcatheter Pulmonary Valve Market by Technology and Geography - Forecast and Analysis 2022-2026: The transcatheter pulmonary valve market share is expected to increase by USD 51.74 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 6.1%.
IVD Market Scope in the US |
Report Coverage |
Details |
Page number |
120 |
Base year |
2020 |
Forecast period |
2021-2025 |
Growth momentum & CAGR |
Decelerate at a CAGR of 6.41% |
Market growth 2021-2025 |
$ 7.39 billion |
Market structure |
Fragmented |
YoY growth (%) |
8.97 |
Competitive landscape |
Leading companies, Competitive Strategies, Consumer engagement scope |
Key companies profiled |
Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Sysmex Corp., and Thermo Fisher Scientific Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Browse for Technavio "Health Care" Research Reports
Table of Contents
1. Executive Summary
1.1 Market Overview
Exhibit 01: Key Finding 1
Exhibit 02: Key Finding 2
Exhibit 03: Key Finding 6
Exhibit 04: Key Finding 7
2. Market Landscape
2.1 Market ecosystem
2.1.1 Parent Market
Exhibit 05 Parent market
Exhibit 06: Market characteristics
2.2 Value Chain Analysis
Exhibit 07: Value Chain Analysis: Healthcare Equipment
2.2.1 Research and development
2.2.2 Inputs
2.2.3 Operations
2.2.4 Distribution
2.2.5 Marketing and sales
2.2.6 Post-sales and services
2.2.7 Industry innovations
3. Market Sizing
3.1 Market Definition
Exhibit 08: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 09: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021 - 2026
3.4.1Estimating growth rates for emerging and high-growth markets
3.4.2Estimating growth rates for mature markets
Exhibit 10: Global - Market size and forecast 2020 - 2025 ($ billion)
Exhibit 11: Global market: Year-over-year growth 2020 - 2025 (%)
4. Five Forces Analysis
4.1 Five Forces Summary
Exhibit 12: Five forces analysis 2020 - 2025
4.2 Bargaining power of buyers
Exhibit 13: Bargaining power of the buyer
4.3 Bargaining power of suppliers
Exhibit 14: Bargaining power of the supplier
4.4 Threat of new entrants
Exhibit 15: Threat of new entrants
4.5 Threat of substitutes
Exhibit 16: Threat of substitutes
4.6 Threat of rivalry
Exhibit 17: Threat of rivalry
4.7 Market condition
Exhibit 18: Market condition - Five forces 2020
5. Market Segmentation by Technology
5.1 Market segments
Exhibit 19: Technology- Market share 2020 - 2025 (%)
5.2 Comparison by Technology
Exhibit 20: Comparison by Technology
5.3 Immunochemistry - Market size and forecast 2020-2025
Exhibit 21: Immunochemistry - Market size and forecast 2020-2025 ($ billion)
Exhibit 22: Immunochemistry - Year-over-year growth 2020-2025 (%)
5.4 Molecular diagnostics - Market size and forecast 2020-2025
Exhibit 23: Molecular diagnostics - Market size and forecast 2020-2025 ($ billion)
Exhibit 24: Molecular diagnostics - Year-over-year growth 2020-2025 (%)
5.5 Tissue diagnostics - Market size and forecast 2020-2025
Exhibit 25: Tissue diagnostics - Market size and forecast 2020-2025 ($ billion)
Exhibit 26: Tissue diagnostics - Year-over-year growth 2020-2025 (%)
5.6 Hematology - Market size and forecast 2020-2025
Exhibit 27: Hematology - Market size and forecast 2020-2025 ($ billion)
Exhibit 28: Hematology - Year-over-year growth 2020-2025 (%)
5.7 Others - Market size and forecast 2020-2025
Exhibit 29: Others - Market size and forecast 2020-2025 ($ billion)
Exhibit 30: Others - Year-over-year growth 2020-2025 (%)
5.8 Market opportunity by Technology
Exhibit 31: Market opportunity by Technology
6 Market Segmentation by Component
6.1 Market segments
Exhibit 32: Component- Market share 2021-2026 (%)
6.2 Comparison by Component
Exhibit 33: Comparison by Component
6.3 Consumables - Market size and forecast 2020-2025
Exhibit 34: Consumables - Market size and forecast 2020-2025 ($ billion)
Exhibit 35: Consumables - Year-over-year growth 2020-2025 (%)
6.4 Instruments - Market size and forecast 2020-2025
Exhibit 36: Instruments - Market size and forecast 2020-2025 ($ billion)
Exhibit 37: Instruments - Year-over-year growth 2020-2025 (%)
6.5 Services - Market size and forecast 2020-2025
Exhibit 38: Services - Market size and forecast 2020-2025 ($ billion)
Exhibit 39: Services - Year-over-year growth 2020-2025 (%)
6.6 Market opportunity by Component
Exhibit 40: Market opportunity by Component
7. Customer landscape
Technavio's customer landscape matrix compares Drivers or price sensitivity, Adoption lifecycle, importance in customer price basket, Adoption rate, and Key purchase criteria
7.1 Overview
Exhibit 41: Customer landscape
8. Drivers, Challenges, and Trends
8.1 Market drivers
8.1.1 Increasing geriatric population, chronic, and infectious diseases
8.1.2 High demand for personalized medicine
8.1.3 Industry developments
8.2 Market challenges
1.1.1 Stringent regulatory bodies guiding IVD manufacturers
1.1.2 Lack of skilled professionals
1.1.3 Inadequate reimbursements
1.1.4 Reduction in profits of manufacturers due to US medical device tax policies
Exhibit 42: Impact of drivers and challenges
8.3 Market trends
8.3.1 Technological advances in IVD
8.3.2 Adoption of advanced treatment solutions
8.3.3 Innovations in the digital IVD sector
8.3.4 Growing adoption of automated diagnostic devices in the healthcare industry
9. Vendor Landscape
9.1 Overview
Exhibit 43: Vendor landscape
9.2 Landscape disruption
Exhibit 44: Landscape disruption
Exhibit 45: Industry Risk
9.3 Competitive Landscape
10. Vendor Analysis
10.1 Vendors covered
Exhibit 46: Vendors covered
10.2 Market positioning of vendors
Exhibit 47:?Market positioning of vendors?
10.3 Abbott Laboratories
Exhibit 48: Abbott Laboratories - Overview
Exhibit 49: Abbott Laboratories - Business segments
Exhibit 50: Abbott Laboratories - Key offerings
Exhibit 51: Abbott Laboratories - Segment focus
10.4 Becton Dickinson and Co.
Exhibit 52: Becton Dickinson and Co. - Overview
Exhibit 53: Becton Dickinson and Co. - Business segments
Exhibit 54: Becton Dickinson and Co. - Key offerings
Exhibit 55: Becton Dickinson and Co. - Segment focus
10.5 Bio Rad Laboratories Inc.
Exhibit 56: Bio Rad Laboratories Inc. - Overview
Exhibit 57: Bio Rad Laboratories Inc. - Business segments
Exhibit 58: Bio Rad Laboratories Inc. - Key offerings
Exhibit 59: Bio Rad Laboratories Inc. - Segment focus
10.6 bioMerieux SA
Exhibit 60: bioMerieux SA - Overview
Exhibit 61: bioMerieux SA - Product and service
Exhibit 62: bioMerieux SA - Key offerings
10.7 Danaher Corp.
Exhibit 63: Danaher Corp. - Overview
Exhibit 64: Danaher Corp. - Business segments
Exhibit 65: Danaher Corp. - Key news
Exhibit 66: Danaher Corp. - Key offerings
Exhibit 67: Danaher Corp. - Segment focus
10.8 DiaSorin SpA
Exhibit 68: DiaSorin SpA - Overview
Exhibit 69: DiaSorin SpA - Business segments
Exhibit 70: DiaSorin SpA - Key offerings
Exhibit 71: DiaSorin SpA - Segment focus
10.9 F. Hoffmann-La Roche Ltd.
Exhibit 72: F. Hoffmann-La Roche Ltd. - Overview
Exhibit 73: F. Hoffmann-La Roche Ltd. - Business segments
Exhibit 74: F. Hoffmann-La Roche Ltd. - Key offerings
Exhibit 75: F. Hoffmann-La Roche Ltd. - Segment focus
10.10 Siemens Healthineers AG
Exhibit 76: Siemens Healthineers AG - Overview
Exhibit 77: Siemens Healthineers AG - Business segments
Exhibit 78: Siemens Healthineers AG - Key offerings
Exhibit 79: Siemens Healthineers AG - Segment focus
10.11 Sysmex Corp
Exhibit 80: Sysmex Corp. - Overview
Exhibit 81: Sysmex Corp. - Business segments
Exhibit 82: Sysmex Corp. - Key news
Exhibit 83: Sysmex Corp. - Key offerings
Exhibit 84: Sysmex Corp. - Segment focus
10.12 Thermo Fisher Scientific Inc.
Exhibit 85: Thermo Fisher Scientific Inc. - Overview
Exhibit 86: Thermo Fisher Scientific Inc. - Business segments
Exhibit 87: Thermo Fisher Scientific Inc. - Key news
Exhibit 88: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 89: Thermo Fisher Scientific Inc. - Segment focus
11. Appendix
11.1 Scope of the report
11.1.1 Market Definition
11.1.2 Objectives
11.1.3 Notes and caveats
11.2 Currency conversion rates for US$
Exhibit 90: Currency conversion rates for US$
11.3 Research Methodology
Exhibit 91: Research Methodology
Exhibit 92: Validation techniques employed for market sizing
Exhibit 93: Information sources
11.4 List of abbreviations
Exhibit 94: List of abbreviations
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article